Cargando…

Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)

L-type Amino acid Transporter 1 (LAT1) plays a significant role in the growth and propagation of cancer cells by facilitating the cross-membrane transport of essential nutrients, and is an attractive drug target. Several halogen-containing L-phenylalanine-based ligands display high affinity and high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Natesh, Villoutreix, Bruno O., Ecker, Gerhard F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803698/ https://www.ncbi.nlm.nih.gov/pubmed/31636293 http://dx.doi.org/10.1038/s41598-019-51455-8

Ejemplares similares

Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
por: Singh, Natesh, et al.
Publicado: (2018)

Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
por: Singh, Natesh, et al.
Publicado: (2018)

Ligand Pose and Orientational Sampling in Molecular Docking
por: Coleman, Ryan G., et al.
Publicado: (2013)

Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021)

A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein–Protein Interfaces
por: Singh, Natesh, et al.
Publicado: (2022)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Exhaustive Sampling of Docking Poses Reveals Binding Hypotheses for Propafenone Type Inhibitors of P-Glycoprotein
por: Klepsch, Freya, et al.
Publicado: (2011)

The impact of cross-docked poses on performance of machine learning classifier for protein–ligand binding pose prediction
por: Shen, Chao, et al.
Publicado: (2021)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
por: Salisbury, Travis B, et al.
Publicado: (2018)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019)

The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
por: Demura, Satoru, et al.
Publicado: (2021)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

MS-DOCK: Accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening
por: Sauton, Nicolas, et al.
Publicado: (2008)

Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABA(A) Receptor by Molecular Modeling
por: Singh, Natesh, et al.
Publicado: (2020)

Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
por: Ikotun, Oluwatayo F., et al.
Publicado: (2013)

Positive Regulation of Decidualization by l-Type Amino Acid Transporter 1 (lat1) in Pregnant Mice
por: Wang, Xiaojie, et al.
Publicado: (2016)

Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia
por: Jia, Xiaotong, et al.
Publicado: (2022)

Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
por: Ueda, Shiho, et al.
Publicado: (2019)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter
por: Barthelemy, Céline, et al.
Publicado: (2019)

ATP modulates SLC7A5 (LAT1) synergistically with cholesterol
por: Cosco, Jessica, et al.
Publicado: (2020)

Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter
por: Yan, Renhong, et al.
Publicado: (2021)

Machine-learning scoring functions for identifying native poses of ligands docked to known and novel proteins
por: Ashtawy, Hossam M, et al.
Publicado: (2015)

COACH-D: improved protein–ligand binding sites prediction with refined ligand-binding poses through molecular docking
por: Wu, Qi, et al.
Publicado: (2018)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer
por: Shindo, Haruhiko, et al.
Publicado: (2021)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy
por: Hodson, Nathan, et al.
Publicado: (2017)

Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells
por: Srisongkram, Tarapong, et al.
Publicado: (2019)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Dysfunctional LAT2 Amino Acid Transporter Is Associated With Cataract in Mouse and Humans
por: Knöpfel, Emilia Boiadjieva, et al.
Publicado: (2019)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Plasma citrulline correlates with basolateral amino acid transporter LAT4 expression in human small intestine
por: Maric, Stefano, et al.
Publicado: (2021)

A toolkit for covalent docking with GOLD: from automated ligand preparation with KNIME to bound protein–ligand complexes
por: David, Laurianne, et al.
Publicado: (2022)

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
por: Hugele, Agathe, et al.
Publicado: (2022)

Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B(0)AT2 and y(+)LAT1 functional cooperation
por: Taslimifar, Mehdi, et al.
Publicado: (2021)

Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
por: Singh, Natesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0t16muvjdvr575fgcu77d7lb9